{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:14:52Z","timestamp":1790388892653,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.leukres.2013.03.004","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T17:20:01Z","timestamp":1364318401000},"page":"963-969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma"],"prefix":"10.1016","volume":"37","author":[{"given":"Charles O.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine","family":"Schibler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghuang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apollina","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.03.004_bib0005","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.leukres.2013.03.004_bib0010","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2013.03.004_bib0015","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12185-011-0949-x","article-title":"Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma","volume":"94","author":"Abe","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2013.03.004_bib0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jcb.23387","article-title":"Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma","volume":"113","author":"Goel","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.leukres.2013.03.004_bib0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrclinonc.2012.15","article-title":"Latest advances and current challenges in the treatment of multiple myeloma","volume":"9","author":"Mahindra","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.leukres.2013.03.004_bib0030","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/sj.onc.1205205","article-title":"Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays","volume":"21","author":"Chauhan","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2013.03.004_bib0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood.V98.3.771","article-title":"Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays","volume":"98","author":"De Vos","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.03.004_bib0040","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","article-title":"Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib","volume":"109","author":"Mulligan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.03.004_bib0045","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","article-title":"Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells","volume":"99","author":"Zhan","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.03.004_bib0050","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1089\/ars.2006.8.1249","article-title":"Redox signaling in cancer biology","volume":"8","author":"Gius","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.leukres.2013.03.004_bib0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/B:CANC.0000031769.14728.bc","article-title":"Metabolic oxidation\/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology","volume":"23","author":"Spitz","year":"2004","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.leukres.2013.03.004_bib0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1155\/MI.2005.171","article-title":"Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma","volume":"2005","author":"Kuku","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.leukres.2013.03.004_bib0065","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/10428190902802323","article-title":"Study of antioxidant levels in patients with multiple myeloma","volume":"50","author":"Sharma","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2013.03.004_bib0070","first-page":"69","article-title":"Antioxidant enzymes and lipid peroxidation in patients with multiple myeloma","volume":"43","author":"Zima","year":"1996","journal-title":"Neoplasma"},{"key":"10.1016\/j.leukres.2013.03.004_bib0075","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00011-012-0498-7","article-title":"Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions","volume":"61","author":"Gangemi","year":"2012","journal-title":"Inflamm Res"},{"key":"10.1016\/j.leukres.2013.03.004_bib0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cbf.1127","article-title":"Oxidant\/antioxidant parameters and their relationship with medical treatment in multiple myeloma","volume":"23","author":"Kuku","year":"2005","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.leukres.2013.03.004_bib0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: evolving genetic events and host interactions","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2013.03.004_bib0090","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1042\/BJ20112019","article-title":"Interleukin-6 counteracts therapy-induced cellular oxidative stress in multiple myeloma by up-regulating manganese superoxide dismutase","volume":"444","author":"Brown","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.leukres.2013.03.004_bib0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.exphem.2012.10.002","article-title":"Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-kappaB activity","volume":"41","author":"Salem","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2013.03.004_bib0100","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/hmg\/7.6.1039","article-title":"CSR, a scavenger receptor-like protein with a protective role against cellular damage causedby UV irradiation and oxidative stress","volume":"7","author":"Han","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.leukres.2013.03.004_bib0105","doi-asserted-by":"crossref","first-page":"e1000829","DOI":"10.1371\/journal.ppat.1000829","article-title":"An accessory to the \u2018Trinity\u2019: SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses","volume":"6","author":"DeWitte-Orr","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.leukres.2013.03.004_bib0110","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.clinbiochem.2007.06.007","article-title":"Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer","volume":"40","author":"Delimaris","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.leukres.2013.03.004_bib0115","first-page":"69","article-title":"Antibodies against ox-LDL serum levels in patients with hepatocellular carcinoma","volume":"45","author":"Motta","year":"2003","journal-title":"Panminerva Med"},{"key":"10.1016\/j.leukres.2013.03.004_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.03.036","article-title":"Biochemistry and cell biology of mammalian scavenger receptors","volume":"182","author":"Murphy","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.leukres.2013.03.004_bib0125","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1593\/neo.101146","article-title":"Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesis","volume":"12","author":"Bera","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.leukres.2013.03.004_bib0130","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","article-title":"A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1","volume":"109","author":"Shaughnessy","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.03.004_bib0135","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1182\/blood-2007-10-119321","article-title":"High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone","volume":"111","author":"Zhan","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.03.004_bib0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.bi.58.070189.000455","article-title":"Biochemistry of oxygen toxicity","volume":"58","author":"Cadenas","year":"1989","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.leukres.2013.03.004_bib0145","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.180.2.705","article-title":"Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function","volume":"180","author":"de Villiers","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2013.03.004_bib0150","doi-asserted-by":"crossref","first-page":"17661","DOI":"10.1074\/jbc.275.23.17661","article-title":"Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation","volume":"275","author":"Mietus-Snyder","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2013.03.004_bib0155","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1161\/01.ATV.20.8.1860","article-title":"Hepatic and extrahepatic scavenger receptors: function in relation to disease","volume":"20","author":"Terpstra","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.leukres.2013.03.004_bib0160","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0022-2275(20)38230-4","article-title":"Induction of acetyl-LDL receptor activity by phorbol ester in human monocyte cell line THP-1","volume":"30","author":"Via","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1016\/j.leukres.2013.03.004_bib0165","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1161\/01.ATV.0000229218.97976.43","article-title":"Scavenger receptors in atherosclerosis: beyond lipid uptake","volume":"26","author":"Moore","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.leukres.2013.03.004_bib0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mrrev.2008.03.002","article-title":"Inflammation: gearing the journey to cancer","volume":"659","author":"Kundu","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.leukres.2013.03.004_bib0175","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/ars.2007.1957","article-title":"Redox regulation of cell survival","volume":"10","author":"Trachootham","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.leukres.2013.03.004_bib0180","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.ATV.17.5.969","article-title":"Regulation of scavenger receptor expression in smooth muscle cells by protein kinase C: a role for oxidative stress","volume":"17","author":"Mietus-Snyder","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.leukres.2013.03.004_bib0185","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood-2005-09-3870","article-title":"Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma","volume":"107","author":"Goel","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2013.03.004_bib0190","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2353\/ajpath.2006.050620","article-title":"CSR1 suppresses tumor growth and metastasis of prostate cancer","volume":"168","author":"Yu","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.leukres.2013.03.004_bib0195","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.humpath.2011.06.003","article-title":"SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions","volume":"43","author":"Bock","year":"2012","journal-title":"Hum Pathol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613000799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613000799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:58:09Z","timestamp":1758934689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613000799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0145212613000799"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.03.004","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2013.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}